admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Pα+ Library: Bifurcated Scheduling

PT466 – The Philosophy of Alfred North Whitehead: Understanding Reality and...

PT465 – Beta-carbolines, Haoma, and Syrian Rue: Rediscovering Ancestral Knowledge

From Stress Relief to Better Sleep: How Wearables Can Improve Psychedelic...

Navigating Psychedelic Spiritual Emergencies

Pα+ Psychedelic Bulletin #150: Drug Development and Research Updates

PT464 – Bodywork, Somatic Literacy, and Understanding Trauma: The Mind and...

Psychedelica Europa: A Deep Dive Into the Latest Psychedelic Research, Regulations...

Pα+ Psychedelic Patent Analysis (October 2023)

PT463 – Bringing Intention, Ceremony, and Inner Healing Intelligence to Modern...

1...363738...218 Page 37 of 218

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin